![Marc Daukandt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Marc Daukandt first degree
Entity | Entity type | Industry | |
---|---|---|---|
Xpress Biologics SA
![]() Xpress Biologics SA BiotechnologyHealth Technology Xpress Biologics SA develops and produces bio molecules for medical applications. It engages in design of expression systems, process development and manufacturing of new biologics, biosimilars and biobetters, management of the pre-clinical and clinical trials and management of the GMP manufacturing services. The company was founded by Marc Daukandt, Philippe Ledent and Christian Rodriguez on April 14, 2014 and is headquartered in Milmort, Belgium.
3
| Subsidiary | Biotechnology | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Marc Daukandt via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ING Belgium SA/NV
![]() ING Belgium SA/NV Investment Banks/BrokersFinance ING Belgium SA/NV is the wholly owned securities broker/dealer subsidiary of ING Groep NV (AMS: INGA) in The Netherlands. Headquartered in Brussels, the firm provides brokerage services to various investors. | Investment Banks/Brokers | Economist | |
Pepscan Holding NV
![]() Pepscan Holding NV Pharmaceuticals: MajorHealth Technology Pepscan Holding NV operates as a holding company with interest in developing immunotherapeutic products in oncology. It offers proprietary technologies for the design, manufacture and use of large combinatorial arrays of peptides, peptide constructs, peptidometics and peptide derivatives. The firm operates through its subsidiaries Pepscan Systems BV and Pepscan Therapeutics BV. The company was founded in 2007 and is headquartered in Lelystad, the Netherlands. | Pharmaceuticals: Major | Chief Executive Officer | |
Pepscan Therapeutics BV
![]() Pepscan Therapeutics BV Pharmaceuticals: MajorHealth Technology Pepscan Therapeutics BV develops immunotherapeutic products in oncology. The company was founded in 2000 and is headquartered in Lelystad, the Netherlands. | Pharmaceuticals: Major | Chief Executive Officer |
Statistics
International
Netherlands | 3 |
Belgium | 2 |
Sectoral
Health Technology | 3 |
Finance | 2 |
Operational
Director/Board Member | 3 |
Chief Executive Officer | 3 |
Founder | 2 |
Economist | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Most connected contacts
Insiders | |
---|---|
Carola Jüstel | 3 |
Philippe Ledent | 2 |
Christian Rodriguez | 1 |
- Stock Market
- Insiders
- Marc Daukandt
- Company connections